drugset / Trial / NCT04199013

Comparison of Ropivacaine With or Without Fentanyl in Spinal Anaesthesia for Lower Limb Surgeries

NCT04199013 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

There has been a wide variety of use of anaesthetic agents along with adjuncts during subarachnoid block. The quest for attaining adequate analgesia and anaesthesia has always been shadowed by the concurrent deleterious effect of the anaesthetic agent. Ropivacaine as an anesthetic agent has proven to meet the desired goals of anaesthesia while minimizing the potential side effects. The addition of different adjuncts has shown to enhance the analgesic property, prolong the duration of sensory blockade and decrease the dose related adverse effects of the local anaesthetics. Fentanyl in this regards has also shown some promising effects. Thus we compare the use of ropivcaine as a single agent versus ropivacaine along with an adjunct (Fentanyl) to attain the desired anesthetic effect while minimizing the associated side effects.

Timeline

Start
2020-01-10
Primary completion
2020-03
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 25 ug Other
Comparator Ropivacaine Other / unclassified 18.75 mg Other

Indications